Intal compound is a new preparation for asthma marketed by Fisons Pharmaceuticals. Before it was launched the parent company told a newspaper ‘we believe it to be 100% effective’,1 but this statement was probably aimed at investors rather than doctors or patients. The preparation is a mixture of disodium cromoglycate 20 mg, isoprenaline sulphate 0.1 mg and lactose and is dispensed as a fine powder in a capsule for release from a special inhaler.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.